References
- 1. S. S. Liou, W. L. Sheih, T. H. Cheng, S. J. Won and C. N. Lin, γ-Pyrone compounds as potential anticancer drugs, J. Pharm. Parmacol.45 (1993) 791–794; https://doi.org/10.1111/j.2042-7158.1993.tb05686.x
- 2. K. Muharrem, D. Ersin and B. Hatice, Synthesis, characterization and antimicrobial activity of novel xanthene sulfonamide and carboxamide derivatives, J. Enzyme Inhib. Med. Chem.28 (2013) 885–893; https://doi.org/10.3109/14756366.2012.692087
- 3. B. C. Baguley and L. M. Ching, Immunomodulatory actions of xanthenone anticancer agents, BioDrugs8 (1997) 119–127; https://doi.org/10.2165/00063030-199708020-00005
- 4. A. E. Hay, M. C. Aumond, S. Mallet, V. Dumontet, M. Litaudon, D. Rondeau and P. Richomme, Antioxidant xanthones from Garcinia vieillardii, J. Nat. Prod.67 (2004) 707–709; https://doi.org/10.1021/np0304971
- 5. Z. Karimi-Jaberi and M. M. Hashemi, One step synthesis of 14-alkyl-or aryl-14H-dibenzo [a,j] xanthenes using sodium hydrogen sulfate as catalyst, Monatsh. Chem.139 (2008) 605–608; https://doi.org/10.1007/s00706-007-0786-z
- 6. S. Laphookhieo, J. K. Syers, R. Kiattansakul and K. Chantrapromma, Cytotoxic and antimalarial prenylated xanthones from Cratoxylum cochinchinense, Chem. Pharm. Bull.54 (2006) 745–747; https://doi.org/10.1248/cpb.54.745
- 7. Q. B. Han, N. Y. Yang, H. L. Tian, C. F. Qiao, J. Z. Song, D. C. Chang, S. L. Chen, K. Q. Luo and H. X. Xu, Xanthones with growth inhibition against HeLa cells from Garcinia xipshuanbannaensis, Phytochemistry69 (2008) 2187–2192; https://doi.org/10.1016/j.phytochem.2008.05.019
- 8. S. L. Niu, Z. L. Li, F. Ji, G. Y. Liu, N. Zhao, X. Q. Liu, Y. K. Jing and H. M. Hua, Xanthones from the stem bark of Garcinia bracteata with growth inhibitory effects against HL-60 cells, Phytochemistry77 (2012) 280–286; https://doi.org/10.1016/j.phytochem.2012.01.010
- 9. A. Nersesyan, E. Perrone, P. Roggieri and C. Bolognesi, Genotoxic action of cycloplatam, a new platinum antitumor drug, on mammalian cells in vivo and in vitro, Chemotherapy49 (2003) 132–137; https://doi.org/10.1159/000070619
- 10. G. P. Machado, J. I. González Borroto, N. Castañedo, A. Creus and R. Marcos, In vitro genotoxicity testing of the furylethylene derivative UC-245 in human cells, Mutagenesis 19 (2004) 75–80; https://doi.org/10.1093/mutage/geg039
- 11. A. K. Nersesyan, G. S. Melikyan and H. Stopper, The study of genotoxicity of two newly synthesized pyrrolinone derivatives on L5178Y mouse lymphoma and bone marrow cells, Exp. Oncol.25 (2003) 176–179.
- 12. F. Karaer, Environmental pollution and carcinogenic risk, J. Environ. Pathol., Toxicol. Oncol.15 (1996) 105–113.
- 13. M. S. Legator and W. W. Au, Application of integrated genetic monitoring: the optimal approach for detecting environmental carcinogens, Environ. Health Perspect.102 (1994) 125–132; https://doi.org/10.1289/ehp.94102s9125
- 14. M. Fenech, Cytokinesis-block micronucleus cytome assay, Nat. Protoc.2 (2007) 1084; https://doi.org/10.1038/nprot.2007.77
- 15. L. Applova, E. Veljović, S. Muratović, J. Karličkova, K. Macakova, D. Završnik, L. Saso, K. Durić and P. Mladenka, 9-(4’-Dimethylaminophenyl)-2,6,7-trihydroxy-xanthene-3-one is a Potentially Novel Antiplatelet Drug which Antagonizes the Effect of Thromboxane A2, Med. Chem.14 (2018) 1–10; https://doi.org/10.2174/1573406413666171010102535
- 16. E. Veljović, S. Špirtović-Halilović, S. Muratović, M. Salihović, I. Novaković, A. Osmanović and D. Završnik, Antimicrobial Activity and Docking Study of Synthesized Xanthen-3-one Derivatives, Res. J. Pharm. Biol. Chem. Sci.9 (2018) 777–783.
- 17. H. Marona, N. Szkaradek, E. Karczewska, D. Trojanowska, A. Budak, P. Bober, W. Przepiorka, M. Cegla and E. Szneler, Antifungal and Antibacterial Activity of the Newly Synthesized 2-Xanthone Derivatives, Arch. Pharm.342 (2009) 9–18; https://doi.org/10.1002/ardp.200800089
- 18. S. Gobbi, A. Rampa, A. Bisi, F. Belluti, P. Valenti, A. Caputo, A. Zampiron and M. Carrara, Synthesis and antitumor activity of new derivatives of xanthen-9-one-4-acetic acid, J. Med. Chem.45 (2002) 4931–4939; https://doi.org/10.1021/jm020929p
- 19. X. Z. Wang, J. H. Yao, G. B. Jiang, J. Wang, H. L. Huang and Y. L. Liu, Synthesis, characterization, cytotoxicity, apoptosis and cell cycle arrest of dibenzoxanthenes derivatives, Spectrochim. Acta, Part A133 (2014) 559–567; https://doi.org/10.1016/j.saa.2014.05.054
- 20. E. Veljović, S. Špirtović-Halilović, S. Muratović, L. Valek Žulj, S. Roca, S. Trifunović, A. Osmanović and D. Završnik, 9-Aryl Substituted Hydroxylated Xanthen-3-ones: Synthesis, Structure and Antioxidant Potency Evaluation, Croat. Chem. Acta88 (2015) 121–127; https://doi.org/10.5562/cca2595
- 21. S. Petra, G. Klaus and R. W. Siegfries, Reliable synthesis of 9-aryl-substituted 2,6,7-trihydroxyxanthen-3-ones, Synthesis14 (2008) 2211–2216; https://doi.org/10.1055/s-2008-1078447
- 22. T. Gazivoda, S. Raić-Malić, S. Krištafor, D. Makuc, J. Plavec, S. Bratulić, S. Kraljević Pavelić, K. Pavelić, L. Naesens, G. Andrei, R. Snoeck, J. Balzarini and M. Mintas, Synthesis, cytostatic and anti-HIV evaluations of the new unsaturated acyclic C-5 pyrimidine nucleoside analogues, Bioorg. Med. Chem.16 (2008) 5624–5634; https://doi.org/10.1016/j.bmc.2008.03.074
- 23. G. M. Morris, R. Huey, W. Lindstrom, M. F. Sanner, R. K. Belew, D. S. Goodsell and A. J. Olson, AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility J. Comput. Chem.30 (2009) 2785–2791; https://doi.org/10.1002/jcc.21256
- 24. M. A. Lill and M. L. Danielson, Computer-aided drug design platform using PyMOL, J. Comput.-Aided Mol. Des.25 (2011) 13–19; https://doi.org/10.1007/s10822-010-9395-8
- 25. M. Fenech, The in vitro micronucleus technique, Mutat. Res., Fundam. Mol. Mech. Mutagen.455 (2000) 81–95; https://doi.org/10.1016/S0027-5107(00)00065-8
- 26. M. Fenech, W. P. Chang, M. Kirsch-Volders, N. Holland, S. Bonassi and E. Zeiger, HUMN project: detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures, Mutat. Res., Genet. Toxicol. Environ. Mutagen.534 (2003) 65–75; https://doi.org/10.1016/S1383-5718(02)00249-8
- 27. O. Hammer, D. A. T. Harper and P. D. Ryan, PAST-Palaeontological statistics. www.uv.es/~pardomv/pe/2001_1/past/pastprog/past.pdf, acessado em, 25 (2001) 2009.
- 28. J. Azizian, M. K. Mohammadi, O. Firuzi, N. Razzaghi-asl and R. Miri, Synthesis, biological activity and docking study of some new isatin Schiff base derivatives, Med. Chem. Res.21 (2012) 3730–3740; https://doi.org/10.1007/s00044-011-9896-6
- 29. E. Gordian, E. Welsh and T. Muñoz-Antonia, Alvespimycin (17-DMAG) blocks TGFβ-induced EMT and migration in A549 lung cancer cells, Cancer Res.74 (2014) 1916–1930; https://doi.org/10.1158/1538-7445.AM2014-1050
- 30. P. Xia, F. F. Mou and L. W. Wang, Predictive Role of Computer Simulation in Assessing Signaling Pathways of Crizotinib-treated A549 Lung Cancer Cells, Asian Pac. J. Cancer Prev.13 (2012) 3119–3121; https://doi.org/10.7314/APJCP.2012.13.7.3119
- 31. A. F. Eweas, Q. M. A. Abdullah and E. S. I. Hassan, Design, synthesis, molecular docking of new thiopyrimidine-5-carbonitrile derivatives and their cytotoxic activity against HepG2 cell line, J. Appl. Pharm. Sci.4 (2014) 102–111; https://doi.org/10.7324/JAPS.2014.41218
- 32. R. J. Coffey, G. D. Shipley and H. L. Moses, Production of transforming growth factors by human colon cancer lines, Cancer Res.46 (1986) 1164–1169.
- 33. F. M. Drumond Chequer, V. P. Venâncio, M. L. Bianchi abd L. M. Antunes, Genotoxic and mutagenic effects of erythrosine B, a xanthene food dye, on HepG2 cells, Food. Chem. Toxicol.50 (2012) 3447–3451; https://doi.org/10.1016/j.fct.2012.07.042
- 34. A. Eisentraeger, C. Brinkmann, H. Hollert, A. Sagner, A. Tiehm and J. Neuwoehner, Heterocyclic compounds: toxic effects using algae, daphnids, and the Salmonella/microsome test taking methodical quantitative aspects into account, Environ. Toxicol. Chem.27 (2008) 1590–1596; https://doi.org/10.1897/07-201.1